Nephrology
Conference Coverage
No invasive strategy benefit at 5 years in ISCHEMIA-CKD extension study
The trial speaks to the lofty high-risk status of patients with CAD. ‘You’re seeing in a group of patients, with largely preserved EF but advanced...
Conference Coverage
Albuminuria linked to higher CVD risk in diabetes
An analysis of more than 74,000 Danish people with type 2 diabetes showed an elevated CVD event rate in those with albuminuria.
Perspectives
Supporting Patients on Complex Care Journeys: How Technology Can Bridge the Gaps
News
Rosuvastatin again linked with risks to kidneys
Practice should more often heed FDA-recommended rosuvastatin dosages for patients with severe chronic kidney disease and step up monitoring for...
Conference Coverage
SGLT2 inhibitors cut AFib risk in real-word analysis
Observational data add to a growing link between SGLT2 inhibitor treatment and atrial fibrillation prevention in people with type 2 diabetes.
News
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
In the absence of additional risk factors, there was no indication of an elevated risk for AKI when an ACE inhibitor and NSAID are combined.
News
Lowering BP according to newest guidance would cut CV events
Two-thirds of patients would need new or intensified hypertension treatment to reach an SBP less than 120 mm Hg, as set in the 2021 KDIGO...
News
Opting out of dialysis not instant death sentence for kidney disease
The study “dispels the notion that conservative care for kidney failure means a grim and near-immediate death.”
News
Community genetic testing prompts behavior change in patients
“These two measurements – the change in blood pressure and increased kidney function tests – act as hallmarks for detecting beneficial lifestyle...
News
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.